Introduction
O ver the last two decades, there has been intense focus on the potential use of stem cells to replace dead or dying neurons in neurodegenerative diseases such as Parkinson's disease (PD). Toward this end, stem cells from a variety of embryonic and adult sources have been studied in vitro and in vivo using a host of differentiation protocols (for review, refs. 1,2). To date, partial success has been achieved. While adult human bone marrow stromal stem cells (hMSCs) are capable of acquiring some dopaminergic traits, they do not fully trans-differentiate into dopamine (DA) neurons nor do they survive long term transplantation into the brain [3] . Greater success has instead been achieved using human embryonic stem (hES) cells that can be differentiated into neurons of a DA phenotype in vitro and in vivo, and which can ameliorate motor defi cits after transplantation into an animal model of PD [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] .
However, ongoing legal, ethical, and practical issues associated with ES cells remain major stumbling blocks to their eventual use in humans. Consequently, researchers continue to search for more practical sources of stem cells in humans. One such alternative source that has received much interest of late is human amniotic fl uid collected during routine amniocenteses. Amniotic fl uid contains a variety of cell types derived from both fetal and amnion tissues, ~1% of which are believed to be amniotic fl uid stem (AFS) cells [15, 16] . Thus, it was of great interest when Atala and colleagues [17] reported recently that they had successfully established human stem cell lines from amniotic fl uid (hAFS). These hAFS cells were capable of unlimited self-renewal and differentiation into derivatives of all three germ layers in culture, sharing overlapping but not identical properties with pluripotent hES cells [17] . Of particular signifi cance, was their ability to express traits of a neural lineage (i.e., nestin and β-tubulin III) in culture and after transplantation into the brain. Unlike their hES cell counterparts, hAFS cells reportedly showed no sign of tumorigenicity in vivo. Thus, hAFS cell lines could provide an abundant, Department of Neurology, Farber Institute for the Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania.
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× 10 6 of undifferentiated (N = 4) or semi-differentiated [cells treated with bFGF in Protocol A (N = 2) or neurospheres generated in Protocol B (N = 8)] hAFS cells, deposited at three stereotaxic levels (AP: +1.2mm, ML: −2.7 mm, DV: −5.4 mm, −4.9 mm and −4.2 mm) in the striatum on the side ipsilateral to the 6-OHDA lesion as described previously [13] . All transplant recipients received cyclosporine A (15 mg/kg, i.p.) daily, beginning 1-2 days before transplantation. Animals with hAFS cell transplants were sacrifi ced at 3 days, 1 and 3 weeks and brains sectioned for immunocytochemical analysis.
Immunocytochemistry
Cultures were rinsed twice in PBS, fi xed with 4% paraformaldehyde and immunocytochemically stained (details described in 14). Antibodies used were: mouse monoclonal anti-Nestin (Chemicon 1:250), rabbit polyclonal anti-homeobox transcription factor 1 alpha (Lmx1; gift from Dr. M. German 1:1,000), mouse monoclonal anti-β-tubulin III (R&D Systems 1:400), goat polyclonal anti-retinaldehyde dehydrogenase (Aldh1a1) (Novus Biologicals 1:500), rabbit polyclonal antityrosine hydroxylase (TH) (Pel-Freez 1:150), sheep polyclonal anti-TH (Abcam 1:1000), rabbit polyclonal anti-glial fi brillary acidic protein (GFAP) (Chemicon 1:1000), rabbit polyclonal antiaromatic l-amino acid decarboxylase (AADC) (Protos Biotech 1:50) mouse monoclonal anti-dopamine transporter (DAT) (Chemicon 1:50). All secondary antibodies were Alexa Fluor antibodies from Invitrogen; donkey anti-rabbit 594, 1:300; donkey anti-rabbit 488, 1:300; donkey anti-mouse 594, 1:300; donkey anti-mouse 488, 1:300.Cultures were mounted in ProLong Gold antifade reagent with DAPI (Invitrogen). Stained cells were counted in representative fi elds (N = 5) on duplicate slides and expressed as a percentage of the total cells.
For immunocytochemical staining in transplantation experiments, rats were perfused with 500 mL of cold (4°C) periodate-lysine-paraformaldehyde (4%). Brains sections were cut at 30 μm on a freezing microtome and processed for immunocytochemistry as described previously [6, 14] . Antibodies were used as above except for the following differences: (β-tubulin III; 1:200), HNA (1:40); GFAP from Chemicon (1:200) and mouse monoclonal anti-CD11 from BD Biosciences (1:25). Brain sections were analyzed along the length of the graft using a Nikon-Scanalytics Image System or a Zeiss LSM510 Confocal Image System.
RNA isolation and cDNA synthesis
Total RNA was isolated directly from freshly collected hAFS neurospheres and H9 StgIV cells with TRIzol (Invitrogen), a modifi cation of the guanidine isothiocyanatephenol-chloroform extraction method. cDNA was synthesized by using 100 ng total RNA in a 20 μL reaction with Superscript III (Invitrogen) and oligo (dT)12-18 (Invitrogen). One microliter of RNase H (Invitrogen) was added to each reaction tube, and the tubes were incubated for 20 min at 37°C before proceeding to polymerase chain reaction (PCR).
PCR amplifi cation
A 0.5 μL cDNA template was used in a 20 μL reaction volume with the PCR master mix (Promega).The cycling parameters were: 94°C, 1 min; 55°C, 1 min; 72°C, 1min, for nontumor-forming source of human stem cells free of ethical dilemma that could be used in cell replacement therapies for diseases like PD. Therefore, in this study, we investigated whether cells derived from hAFS cell lines could indeed be differentiated into neurons, particularly those that express traits of a DA phenotype either in vitro or after transplantation in vivo into PD rats.
Materials and Methods

Cell propagation/differentiation in culture
Cells of the AFS-A1 (Passage 15) and AFS-H1 (Passage 18) cells lines were generously supplied by A. Atala (Wake Forest University, NC). Human AFS cells were cultured on polystyrene (Petri) dishes in α-MEM medium (Invitrogen) containing 18% Chang's Medium B, 2% Chang's Medium C (Irvine Scientifi c), ES-qualifi ed 15% FBS (Invitrogen), 1% L-glutamine and 1% Penicillin/Streptomycin (Invitrogen) at 37°C with 5% CO 2 atmosphere. Cells were passaged at 70% confl uence at a dilution of 1:4 to 1:6 and used for experiments at Passage 15-21 for A1 cells and Passage 18-27 for H1 cells. For differentiation protocols, cells were grown either according to Protocol A in defi ned serum-free (DM) media plus 20 ng/mL of basic fi broblast growth factor (bFGF) for 1 week followed by 1 week in 10 ng/mL aFGF, 200 nM TPA, 20 μM DA, 0.25 mM IBMX plus 50 μM forskolin; or Protocol B as described in Results. Essentially, neurosphere-like clusters were generated from 5 × 10 5 cells grown in suspension in DM + Noggin (200 ng/mL) and maintained for 5-7 days (as described previously in ref. 6 ). Cells were gently lifted with a P1000 pipette and seeded in Ultra-low attachment dishes (Corning). In addition, cells were plated at a high density (100,000-150,000 cells in 25 μL seeded droplet) on chamber slide wells coated with polyornithine, 100ng/cm 2 human collagen IV, 10 ng/mL laminin or 5 μg/mL human plasma fi bronectin and incubated with a variety of other differentiation protocols (Table 2 ).
6-OHDA lesions
Animals were maintained in accord with the Offi ce of Animal Resources at Thomas Jefferson University and IACUC policies. As described previously [14, 18] , 12 Fischer 344 rats (Taconic) were made Parkinsonian for these studies. Briefl y, rats were anesthetized with sodium pentobarbital [30 mg/kg, intraperitoneally (i.p.)], placed in a stereotaxic apparatus (Kopf Instruments) and a 26-gauge Hamilton syringe containing 6-OHDA (Sigma; 20 μg/mL in 4 μL phosphate-buffered saline (PBS) containing 0.2 mg/mL ascorbate) was lowered into the right median forebrain bundle (AP: −4.4mm, ML: −1.2mm, DV: −7.8 mm from bregma). The 6-OHDA solution was gradually injected at a rate of 1 μL/min. All lesions were verifi ed 3 and 6 weeks later by assessment of rotational behavior in an automated rotometer system (Columbus Instruments) following amphetamine challenge (5 mg/kg, i.p.). Only rats with consistent and stable lesions (>10 ipsilateral turns/min on multiple tests) were used for transplantation studies.
Transplantation procedures
Animals with verifi able lesions (>10 ipsilateral turns/ min) were implanted with a total of 10 μL of PBS containing due to the presence of potentially toxic substances like forskolin. Using the hES differentiation protocol developed in this laboratory (Protocol B) (Fig.1B) , hAFS cells were fi rst incubated with 200 ng/mL noggin for 4 days to promote the formation of clusters of neural progenitors. This stage was next followed by a 1 week expansion phase during which cells were propagated as neurospheres in suspension before plating as dissociated cells. Unlike hES cells, hAFS cells did not readily form compact spheres nor did they require subcloning, suggesting that the nestin + cells in these spheres were not dividing as robustly as in hES cell cultures. Finally, when hAFS neurospheres were dissociated into single cells for further differentiation in adherent cultures, we found poor attachment to substrates (polyornithine, laminin, fi bronectin, collagen type IV) previously used to adhere other types of stem cells [3, 6, 14, 17] . Adherence of a small number of dissociated neurosphere (Protocol B) hAFS cells only when polyornithine-coated dishes were also treated with fi bronectin. 30 cycles. The PCR cycles were preceded by an initial denaturation of 3 min at 94°C and followed by a fi nal extension of 10 min at 72°C (details in ref. 14) (primers are listed in Table 1 ).
Results
Undifferentiated hAFS cells were propagated as described previously [17] . We fi rst tested various differentiation protocols (see Table 2 for complete list), beginning with several used successfully to differentiate DA neurons either from hMSCs [3] or hES cells [6] in our laboratory. Undifferentiated hAFS cells, grown according to the mesenchymal protocol (Protocol A) (Fig. 1A) , were fed a defi ned media containing 20 ng/mL of bFGF for 1 week followed by an additional week in the DA differentiation cocktail (10 ng/mL aFGF, 200 nM TPA, 20 μM DA, 0.25 mM IBMX plus 50 μM forskolin) as described previously [3, 18, 19] . This media often produced a high level of cell death after several days in culture, possibly NEFH  NM_021076 TGCGGCGCCACCACCAG  452  GGCGGCCATCTCCCACTTG  GFAP  NM_002055 GTGGGCAGGTGGGAGCTTGATTCT  388  CTGGGGCGGCCTGGTATGACA  AFP  NM_001134 AAATACATCCAGGAGAGCCA  417  CTGAGCTTGGCACAGATCCT  FN  NM_212482 TGTTATGGAGGAAGCCGAGGTTTT  150  CCCGATGCAGGTACAGTCCCAGAT  Lmx1a  AY078391  CTCAATTTAGTGTATGAAGAGG  372  CTACATTCTCTTGGCTGGAC  Aldh1a1  NM_000689 CTGAAATGTGACCCCCAAGT  280  TGACAAGCAGACATGACATCC  Pitx3  NM_005029 GGACTAGGCCCTACACACAGA  151  TCCGCGCACGTTTATTTC  Nurr1  NM_006186 GGCTGAAGCCATGCCTTGT  150  GTGAGGTCCATGCTAAACTTGACA  Girk2  NM_002240 CAACAATGGCCAAGCTGACA  150  TCCGATCTCGGCTGATGTG  AADC  NM_000790 GGGACCACAACATGCTGCTC  145  CCACTCCATTCAGAAGGTGCC  DAT  NM_001044 TCCATCAACTCCCTGACGAGCTTC  500  CTGGGCCGCTGCCCGGTCATCTGC  TH  NM_199292 TCATCACCTGGTCACCAAGTT  125  GGTCGCCGTGCCTGTACT  GAPDH  NM_002046 ACAGTCAGCCGCATCTTCTT 259 GACAAGCTTCCCGTTCTCAG regulated inwardly rectifying potassium channel (Girk2)] by PCR. We found that undifferentiated hAFS cells expressed not only stem cell transcripts, but also markers of the three germ layers, including those associated with an endodermal (AFP), mesodermal (FN) and neurectodermal lineage (nestin, β-tubulin III, human NEFH). Of particular interest was expression of mRNAs normally associated with more differentiated neuronal phenotypes (Fig. 2) . Consequently, early markers of a DA phenotype, such as Lmx1a and Aldh1a1, To assess the degree of differentiation achieved by these cells at various stages in these treatment protocols, we next examined the expression of stem cell (Oct4, Sox2), neural progenitor (nestin, vimentin), neural [β-tubulin III, neurofi lament (NEFP)] glial (GFAP), endodermal [α-fetoprotein (AFP)] and mesodermal (fi bronectin:FN) markers as well as specifi c markers of the DA system, including the DA transcription factors (Lmx1a, Nurr1, Pitx3), enzymes (Aldh1a1, AADC, TH), transporters (DAT) and channels [G-protein Neurocult proliferation media -7 div 3-4+ Plate on P-Orn/fi bronectin and diff in: AFS cells were stained for the presence of cell type specifi c markers after differentiation using a particular treatment protocol. For cultures treated with conditioned media, defi ned media was incubated for 3 days on cultures of P1 rat glia, E14 rat substantia nigra, mouse embryonic fi broblasts (MEF from specialty media), and stage V hES cells as described in ref. 6 . Cultures of viable cells were stained with the markers listed and evaluated for the intensity of staining as follows: none (-), lightly (1+), moderately (2-3+), or darkly (4+) stained cells.
DA-specifying gene Lmx1a were down regulated (Fig. 2) . However, hAFS neurospheres generated in Protocol B continued to express Lmx1a as well as several other transcripts associated with a more differentiated DA phenotype (i.e., Pitx3, Nurr1 and Girk2; Fig. 2) .
Next, sister cultures were stained with antibodies to many of these cell types and DA-specifi c markers. Similar were readily detected by reverse transcription (RT)-PCR while more mature DA markers (AADC, TH, DAT) were not. When hAFS cells were further differentiated by either protocol, we continued to see many of the same transcripts as in the undifferentiated state, with the exception of the disappearance of the endodermal marker AFP (Fig. 2) . In addition, with Protocol A, the stem cell marker Oct 4 and the (Fig. 4A) , and only at their earliest time point examined (3 days after implantation). As shown in Fig. 4A , surviving cells exhibited an immature morphology, expressing markers of neural progenitors (nestin; Fig.  4A ) and neurons (β-tubulin III) but not DA neuron traits (Lmx1a or TH; data not shown). Importantly, when grafts of these same cells were examined at 3 weeks after implantation, no hAFS cells remained at the implantation site (note the absence of HNA staining in Fig. 4B ) nor were HNA + cells found in surrounding brain regions. Residual nestin staining observed in the vicinity of the graft was instead likely due to the presence of host brain progenitors. When these brains were further examined for the presence of reactive glia and macrophage/microglia, we found copious staining for their respective type-specifi c markers, GFAP and CD11 in host cells adjacent to the graft site at 3 days (data not shown) and 3 weeks (Fig. 4C and D) after implantation.
Discussion
This study has examined hAFS cells as an abundant, practical, and ethical source of stem cells to generate neurons for cell replacement therapies. In particular, our laboratory is interested in the differentiation of hAFS cells into functional DA neurons to replace cells lost in PD. We show here that undifferentiated hAFS cells from established cells lines [17] constitutively expressed mRNAs and proteins typical of stem cells but also cell derivatives of all three germ layers, including neural progenitors/neurons (nestin, β-tubulin III, NEFH). Additionally, these undifferentiated cells expressed specifi c transcripts appropriate to an immature DA phenotype (Lmx1a, Pitx-3, Nurr1, Aldh1a1). However, treatment of hAFS cells with various DA differentiation factors using a number of published protocols did little to advance their development into fully differentiated DA neurons. Only cells grown as neurospheres and differentiated as described in Protocol B exhibited an increase in the expression of some DA transcripts. When AFS neurospheres were transplanted in vivo, cells did not survive more than several days following their transplantation into the PD rat brain, likely due to an intense immunorejection response in host tissue. Transplanted cells that did survive in the short term, however, did not express detectable levels of any of DA proteins (Lmx1a, Aldh1a1, AADC, TH, DAT).
The fact that hAFS cells, even after incubation with known neuron-promoting differentiation factors [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] 20] , continued to express transcripts of non-neuronal cell types indicates that hAFS cells behave quite differently from other pluripotent stem cell sources. Thus, hES cells that initially express transcripts from all three germ layers, if grown under the same conditions used here (Protocol B), will proceed down a neural progenitor pathway to selectively become neurons [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Likewise, adult stem cells (hMSCs) grown under similar culture conditions (Protocol A) downregulate mesenchymal (FN) transcripts with the expression of neuronal markers (nestin, β-tubulin III) [3, 20] . In contrast, in this study, undifferentiated hAFS cells expressed to our RT-PCR results, using immunocytochemistry, we found that progenitor protein nestin was robustly expressed in 20-40% of individual undifferentiated hAFS cells (Fig.  1A , 1B insets; Table 2 ). With further differentiation, cells changed in morphological shape but continued to express nestin. Moreover, the proportion of nestin + cells increased, with the greatest number (>80%) found in semi-differentiated cultures (Protocol A) and in neurospheres (Protocol B) ( Table 2 ). In contrast, relatively few (<20%) undifferentiated or semi-differentiated hAFS cells expressed the early neuron marker β-tubulin III (Fig. 3) . The number of β-tubulin III + cells did however increase (40-60%) after the fi nal differentiation step in Protocol A. Because in Protocol B dissociated neurosphere cells did not attach well to adherent substrates, we could not assess the degree of neuronal differentiation in these cultures (Table 2) .
When semi-differentiated or fully differentiated cultures were further probed for the expression of DA marker proteins, importantly, no positively stained cells were observed regardless of their state of differentiation or the protocol used (Table 2) . Thus, Lmx1a-staining cells were not detected by immunocytochemistry in these cultures despite detection of Lmx1a mRNA in pooled cell cultures. Likewise, neither Aldh1a1, AADC, TH nor DAT positive staining was observed in undifferentiated or differentiated AFS cells (Table 2) , unlike other stem cell derivatives studied in our laboratory [3, 6, 14, 18] .
We next sought to determine whether transplantation of hAFS cells into the brain would further foster their development into DA neurons. Thus, undifferentiated (N = 4) and semi-differentiated hAFS cells (cells semi-differentiated with bFGF in Protocol A; N = 2 or neurospheres generated in Protocol B; N = 8) were transplanted into the striata of hemi-lesioned (6-OHDA) immunosuppressed rats on the there was no immunocytochemical evidence for Lmx1a, Aldh1a1, AADC, TH, or DAT in these cells, regardless of their differentiation status or their expression of DA mRNAs. The reasons for this disparity remain unknown but suggest that cells may be trapped in a primitive state, unable to produce critical proteins of a differentiated neuronal subtype using these treatment protocols. Consistent with this possibility is the fact that mature DA phenotypic traits, such as the expression of the key DA rate-limiting enzyme TH or the second enzyme in DA biosynthesis AADC, were never observed at either the transcriptional or protein levels in these cells. Nonetheless, the DA-associated Girk2 channel [21] [22] [23] was detected by RT-PCR both in this study and by Atala and colleagues who also demonstrated its functionality (i.e., barium sensitivity) in culture [17] . As Girk2 expression has also been reported in a variety of non-DA neurons [24] [25] [26] , proof that its expression here represents the acquisition of a bona fi de DA neuronal trait will require experimental corroboration by other methods. Additionally, using different AFS lines and a different DA differentiation protocol, Tsai et al. [27] transcripts for nestin, β-tubulin III and FN, with no shift in the mRNA expression profi le toward a neuronal fate after further differentiation in culture. Although differentiated hAFS cells acquired a neuronal like appearance and stained for neuronal marker proteins, it remains uncertain whether these cells can in fact function as neurons.
Further distinguishing the behavior of hAFS cells from other stem cell types was their acquisition of DA traits. Earlier studies on hMSCs and hES cells demonstrated that DA-related markers that were absent in undifferentiated cells could be partially or fully induced in vitro and in vivo using Protocols A and B, respectively [3, 6, 14, 20] . In contrast, in this study, even in the undifferentiated state, hAFS cells expressed a number of mRNAs normally associated with DA-specifi ed progenitors/neurons but could not be further induced to complete their DA differentiation by incubation using published protocols (Table 2) . Although in Protocol B, neurosphere cells did not survive plating and growth on differentiation medium in order to assess DA protein expression, using Protocol A (and other differentiation schemes)
Immunocytochemical localization of β-tubulin III in amniotic fl uid stem (AFS) cells at various stages of differentiation. AFS cells were stained with β-tubulin III antibodies in the undifferentiated (Undiff) state (A) or after semi-differentiation (Semidiff) (B) and full differentiation (Diff) (C) using procedures described in Protocol A (as shown in Fig. 1 ). While many cells express β-tubulin III in all stages, unseen in imaged fi elds are other cells which do not express the neuronal marker. Note the change in cell shape as cells become more differentiated. showed that small quantities of DA could be detected in the media following KCl-stimulated release. However, they did not provide evidence that AFS cells possessed the DA synthetic machinery (TH, AADC) to manufacture DA as opposed to simply taking up and re-releasing DA found in their (serum-containing) media.
NSTN&HNA
Although the initial report describing these hAFS lines reported long-term survival of cells after transplantation into the lateral ventricles of newborn mice [17] , in our transplantation studies, hAFS cells did not persist in the adult PD rat brain. This was likely due to the acute immunorejection of cells as evidenced by the copious expression of the microglial/macrophage marker CD11 and the reactive glial marker GFAP in host cells near the site of transplantation. This rejection response occurred despite the immunosuppression of rats with Cyclosporin A using a regimen that has successfully supported the long-term survival of other xenotransplanted human stem cells [3, 6, 14] . Similar to our observations, others using the same cell lines, also found an intense immunorejection response after hAFS transplantation into the immunosuppressed and immunodefi cient rat myocardium [28] . Although hAFS cells were originally thought to be non-immunogenic because of their lack in major histocompatibility complex class II molecules, there is now evidence for expression of T-cell co-stimulatory molecules (normally found on antigen presenting cells) that may contribute to their immunorejection after transplantation [28] . Possibly, as a result of the relative immaturity of the newborn immune system, these molecules are less effective thereby allowing the survival of transplanted hAFS cells into the perinatal brain [17] ). Another possible explanation for the rejection of these cells may stem from their heterogeneity, with mesodermal derivatives causing an intense immune/infl ammatory response in the brain [3] . Of the few cells that did survive in the short term after transplantation into the brain, there was little evidence of maturation into fully differentiated neurons or incorporation into surrounding host tissues. A similar lack of neuronal differentiation and integration has recently been observed following the transplantation of human cord blood into the retina [29] .
In sum, our studies have demonstrated that although hAFS cells constituitively express a number of traits normally associated with neural progenitors/immature neurons, they cannot be induced to acquire a fully differentiated DA neuronal phenotype in vitro or in vivo. In addition, these cells are highly immunogenic, inducing an acute rejection response after transplantation into the adult immunosuppressed rat brain. Taken together, these results suggest that further studies will be needed to improve differentiation procedures in culture and to prolong cell survival in vivo if hAFS cells are to be useful as replacement cells in PD therapy.
